ALDX
Aldeyra The
NASDAQ: ALDX · HEALTHCARE · BIOTECHNOLOGY
$1.52
+1.33% today
Updated 2026-04-30
Market cap
$90.48M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.56
Dividend yield
—
52W range
$1 – $6
Volume
3.6M
Aldeyra The (ALDX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.39M | $-778046.00 | $-1.71M | $-4.78M | $-9.31M | $-15.15M | $-19.22M | $-29.86M | $-44.98M | $-37.49M | $-42.56M | $-56.64M | $-30.33M | $-43.21M | $-33.35T |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $14062.00 | $86119.00 | $11810.00 | $24759.00 | $262966.00 | $9529.00 | $5.00 | $7806.00 | $16317.00 | $2.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $49592.00 | $84401.00 | $1.70M | $2.04M | $2.19M | $2.76M | $2.71M | $4.14M | $8.08M | $7.08M | $7.11M | $8.29M | $5.75M | $7.97M | $6.09T |
| Free cash flow | $-2.39M | $-778046.00 | $-1.71M | $-4.79M | $-9.40M | $-15.16M | $-19.25M | $-30.12M | $-44.99M | $-37.49M | $-42.56M | $-56.65M | $-30.33M | $-43.21M | $-33.35T |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $5.26M | $6.12M | $-2.63M | $8.01M | $27.33M | $-2.93M | $33.43M | $151.93M | $-85.37M | — | — | — |